EUCTR2005-000103-34-IT进行中（未招募）不适用
Evaluation of the effects of 3 succesive oral dosages (2.5; 5; 7.5 mg b.i.d.) of ivabradine in patients with stable moderate to severe systolic chronic heart failure treated with beta-blockers A 9 weeks pilot, open labelled, international multicenter study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Evaluation of the effects of 3 successive oral dosages (2.5; 5; 7.5 mg b.i.d.) of ivabradine in patients with stable moderate to severe systolic chronic heart failure treated with beta-blockers. A 9 week pilot, open labelled, international multicenter studyChronic systolic heart failureMedDRA version: 3.3Level: PTClassification code 10007558EUCTR2005-000103-34-DEInstitut de Recherches Internationales Servier80
已完成
3 期
The effect of Erythromycin on feeding intolerance in premature infantsfeeding intolerance.Underfeeding of newbornIRCT20120614010026N10Esfahan University of Medical Sciences84
进行中（未招募）
1 期
DK378 versus chemotherapy in previously untreated patients with ALK rearranged non-small cell lung canceron-small cell lung cancer (NSCLC)MedDRA version: 21.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-000319-26-SEovartis Pharma Services AG346
进行中（未招募）
1 期
DK378 versus chemotherapy in previously untreated patients with ALK rearranged non-small cell lung cancerEUCTR2013-000319-26-PTovartis Pharma Services AG348
进行中（未招募）
不适用
DK378 versus chemotherapy in previously untreated patients with ALK rearranged non-small cell lung cancernon-small cell lung cancer (NSCLC)MedDRA version: 14.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-000319-26-HUovartis Pharma Services AG348